L-DOPA
FDA Approved
Contents
Description
Levodopa, also known as L-DOPA, is a precursor to dopamine that can cross the blood-brain barrier and is converted into dopamine in the brain. It is used to manage symptoms of parkinsonism. It helps to alleviate motor symptoms.
Indications & Therapeutic Use
Parkinson's disease, rare parkinsonian syndrome due to neurodegenerative disease
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source L-DOPA — GNH India
41 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
AA-LEVOCARB CR
100 MGtablet (extended-release)CANADA
AG-LEVOCARB
100 MGtabletCANADA
APO-LEVOCARB
100 MGtabletCANADA
AURO-LEVOCARB
100 MGtabletCANADA
DUODOPA
20 MGgelCANADA
Inbrija
EU
JAMP LEVOCARB
100 MGtabletCANADA
MINT-LEVOCARB
100 MGtabletCANADA
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
L-DOPA
| Generic Name | L-DOPA |
| Brands | 1 brand available |
| Active Ingredient | Levodopa |
| Drug Class | Parkinson's disease |
| Manufacturer | Merck |
| Dosage Forms | Tablet, Capsule |
| Medical Code | N04BA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes